News zum Sektor Gesundheit aus Island

 

Announcement no. 47/2025 13 October 2025 Reykjavik, Iceland/Copenhagen, Denmark, 13 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 6 October to 10 October 2025 Embla Medical has acquired 75,000 shares under the Program at the average price of DKK 31.82. Following the transactions below, the Company holds 2,283,657 shares, corresponding to 0.53% of the...

Announcement no. 46/2025 6 October 2025 Reykjavik, Iceland/Copenhagen, Denmark, 6 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 29 September to 3 October 2025 Embla Medical has acquired 92,000 shares under the Program at the average price of DKK 32.08. Following the transactions below, the Company holds 2,208,657 shares, corresponding to 0.51% of the...

Reykjavik, Iceland/Copenhagen, Denmark, 3 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2025 Report on 21 October 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST. The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English. Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors To participate in the...

Announcement no. 45/2025 29 September 2025 Reykjavik, Iceland/Copenhagen, Denmark, 29 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 22 September to 26 September 2025 Embla Medical has acquired 75,000 shares under the Program at the average price of DKK 33.19. Following the transactions below, the Company holds 2,116,,657 shares, corresponding to 0....

Announcement no. 44/2025 22 September 2025 Reykjavik, Iceland/Copenhagen, Denmark, 22 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 15 September to 19 September 2025 Embla Medical has acquired 60,000 shares under the Program at the average price of DKK 32.29. Following the transactions below, the Company holds 2,041,657 shares, corresponding to 0.47%...

Announcement no. 43/2025 15 September 2025 Reykjavik, Iceland/Copenhagen, Denmark, 15 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 8 September to 12 September 2025 Embla Medical has acquired 25,789 shares under the Program at the average price of DKK 30.62. Following the transactions below, the Company holds 1,981,657 shares, corresponding to 0.46%...

Announcement no. 42/2025 9 September 2025 Reykjavik, Iceland/Copenhagen, Denmark, 9 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 1 September to 5 September 2025 Embla Medical has acquired 29,109 shares under the Program at the average price of DKK 31.93. Following the transactions below, the Company holds 1,955,868 shares, corresponding to 0.45% of...

Announcement no. 41/2025 3 September 2025 Reference is made to announcement no. 39/2025 published on 29 August 2025 (Embla Medical closes the majority share investment in Streifeneder ortho.production GmbH). Reykjavik, Iceland/Copenhagen, Denmark, 3 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that in connection with the majority investment in Streifeneder ortho.production, the Board of Directors of Embla Medical resolved to utilize the authorization in Article 5, paragraph 1, of the Articles...

Announcement no. 40/2025 1 September 2025 Reykjavik, Iceland/Copenhagen, Denmark, 1 September 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 25 August to 29 August 2025 Embla Medical has acquired 33,750 shares under the Program at the average price of DKK 32.21. Following the transactions below, the Company holds 1,926,759 shares, corresponding to 0.45% of the...

Announcement no. 39/2025 29 August 2025 Reference is made to announcement no. 31/2025 published on 17 July 2025 (Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH). REYKJAVIK, Iceland and COPENHAGEN, Denmark, Aug. 29, 2025 /PRNewswire/ --......

Announcement no. 38/2025 25 August 2025 Reykjavik, Iceland/Copenhagen, Denmark, 25 August 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 18 August to 22 August 2025 Embla Medical has acquired 34,500 shares under the Program at the average price of DKK 31.93. Following the transactions below, the Company holds 1,893,009 shares, corresponding to 0.44% of the...

Announcement no. 37/2025 18 August 2025 Reykjavik, Iceland/Copenhagen, Denmark, 18 August 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 11 August to 15 August 2025 Embla Medical has acquired 37,000 shares under the Program at the average price of DKK 30.77. Following the transactions below, the Company holds 1,858,509 shares, corresponding to 0.43% of the...

Announcement no. 36/2025 11 August 2025 Reykjavik, Iceland/Copenhagen, Denmark, 11 August 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 3/2025 dated 7 February 2025. During the period 4 August  to 8 August 2025 Embla Medical has acquired 30,000 shares under the Program at the average price of DKK 31.92. Following the transactions below, the Company holds 1,821,509 shares, corresponding to 0.43% of the...